ML-004 in Adolescents and Adults With Autism Spectrum Disorders (ASD)

PHASE2RecruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

September 13, 2022

Primary Completion Date

October 31, 2026

Study Completion Date

November 30, 2026

Conditions
Autism Spectrum Disorder
Interventions
DRUG

ML-004 (IR)/(ER) tablet

Participants will receive ML-004 once daily.

DRUG

ML-004 Placebo

Participants will receive matching placebo once daily.

Trial Locations (41)

2050

RECRUITING

Brain and Mind Centre, Camperdown

3052

RECRUITING

The Royal Children's Hospital, Murdoch Children's Research Institute, Parkville

4101

WITHDRAWN

Children's Health Queensland Hospital and Health Service, South Brisbane

WITHDRAWN

Mater Research, South Brisbane

5042

WITHDRAWN

Flinders Medical Centre, Adelaide

10314

RECRUITING

Richmond Behavioral Associates, Staten Island

10605

RECRUITING

Center for Autism and the Developing Brain, New York State Psychiatric Institute, White Plains

10962

RECRUITING

Nathan Kline Institute for Psychiatric Research, Orangeburg

19063

RECRUITING

Suburban Research Associates, Media

19104

WITHDRAWN

Children's Hospital of Philadelphia, Philadelphia

20010

RECRUITING

Children's National Health System - The Children's Research Institute (CRI), Washington D.C.

23220

RECRUITING

Virginia Commonwealth University, Richmond

32803

RECRUITING

APG Research, LLC, Orlando

33176

RECRUITING

Abba Medical Group, Miami

33613

RECRUITING

University of South Florida Psychiatry and Behavioral Neurosciences, Tampa

36303

RECRUITING

Harmonex Neuroscience Research, Dothan

43210

TERMINATED

Ohio State University Nisonger Center, Columbus

48302

RECRUITING

Neurobehavioral Medicine Group, Bloomfield Hills

60563

WITHDRAWN

AMR-Baber Research Inc, Naperville

65211

RECRUITING

University of Missouri, Thompson Center for Autism & Neurodevelopmental Disorders, Columbia

77090

TERMINATED

Red Oak Psychiatry Associates, PA, Houston

77381

RECRUITING

Family Psychiatry of The Woodlands, The Woodlands

78249

RECRUITING

Road Runner Research, Ltd., San Antonio

78759

RECRUITING

BioBehavioral Research of Austin, Austin

84020

TERMINATED

Cedar Clinical Research, Draper

85006

RECRUITING

Southwest Autism Research & Resource Center, Clinical Research, Phoenix

91203

RECRUITING

Cortica Healthcare, Glendale

91786

WITHDRAWN

Pacific Clinical Research Management Group, Upland

92868

RECRUITING

NRC Research Institute, Orange

WITHDRAWN

Thompson Autism and Neurodevelopmental Center, Orange

94143

WITHDRAWN

University of California, San Francisco, San Francisco

94903

RECRUITING

Cortica, San Rafael

98105

WITHDRAWN

Seattle Children's Autism Center, Seattle

06519

RECRUITING

Yale Child Study Center, New Haven

02114

RECRUITING

Massachusetts General hospital, Boston

02421

WITHDRAWN

Lurie Center for Autism Massachusetts General Hospital, Lexington

08009

WITHDRAWN

Hassman Research Institute, Berlin

07753

RECRUITING

Jersey Shore University Medical Center, Neptune City

V1Y 1Z9

RECRUITING

OCT Research ULC (dba Okanagan Clinical Trials), Kelowna

N6A 5W9

RECRUITING

Lawson Health Research Institute/ London Health Sciences Centre, London

M4G 1R8

RECRUITING

Holland Bloorview Kids Rehabilitation Hospital, Toronto

Sponsors
All Listed Sponsors
lead

MapLight Therapeutics

INDUSTRY

NCT05081245 - ML-004 in Adolescents and Adults With Autism Spectrum Disorders (ASD) | Biotech Hunter | Biotech Hunter